Delayed malignant hyperthermia after routine coronary artery bypass
M Firstenberg, E Abel, D Blais, M Andritsos - The Annals of thoracic surgery, 2010 - Elsevier
M Firstenberg, E Abel, D Blais, M Andritsos
The Annals of thoracic surgery, 2010•ElsevierMalignant hyperthermia is a rare but well-described hypermetabolic disorder of skeletal
muscle that can be potentially fatal if untreated. In our patient, malignant hyperthermia
developed several minutes after discontinuation of the known triggering agent after an
uncomplicated coronary revascularization. This case illustrates the dramatic presentation
and successful management of a rare disease with a rare onset.
muscle that can be potentially fatal if untreated. In our patient, malignant hyperthermia
developed several minutes after discontinuation of the known triggering agent after an
uncomplicated coronary revascularization. This case illustrates the dramatic presentation
and successful management of a rare disease with a rare onset.
Malignant hyperthermia is a rare but well-described hypermetabolic disorder of skeletal muscle that can be potentially fatal if untreated. In our patient, malignant hyperthermia developed several minutes after discontinuation of the known triggering agent after an uncomplicated coronary revascularization. This case illustrates the dramatic presentation and successful management of a rare disease with a rare onset.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果